戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 en for liver-intestine, and two for isolated intestinal transplant.
2 itric oxide synthase rapidly increased after intestinal transplant.
3 ischemia without imposing constraints on the intestinal transplant.
4  mortality for those on the waiting list for intestinal transplants.
5 ed parenteral nutrition received 28 isolated intestinal transplants.
6 ts on the hemodynamics and function of small intestinal transplants.
7 al nutrition (86% vs. 84%) or have undergone intestinal transplant (28% vs. 23%).
8 on (1 of 19, 5%) when compared with isolated intestinal transplants and modified multivisceral transp
9 nt Registry (ITR) was created in 1985 by the Intestinal Transplant Association to capture the worldwi
10  was sent to IT programs registered with the Intestinal Transplant Association.
11      Twenty-seven adult patients received 29 intestinal transplants between July 2004 and March 2007.
12                        A total of 2744 small intestinal transplant biopsies within 3 months after Itx
13                Since 2006, the number of new intestinal transplant candidates listed each year has de
14  months posttransplant among 445 consecutive intestinal transplant cases at our center since 1994.
15          Using a single-center cohort of 445 intestinal transplant cases to test the prognostic value
16 ll recipients who actually received isolated intestinal transplants during this period.
17                We performed a living-related intestinal transplant for a paraplegic, 16-year-old boy
18                                              Intestinal transplants from living-related donors can be
19                                        After intestinal transplant, immune-mediated dysmotility is co
20                                              Intestinal transplant is an established treatment of irr
21 g complications and need to be evaluated for intestinal transplants (ITs).
22                       Establishment of a new intestinal transplant (Itx) program in the United States
23                                              Intestinal transplant (ITx) rejection lacks a reliable n
24                            In adult isolated intestinal transplant (ITx) retransplants (n=41), patien
25 s a potentially fatal complication following intestinal transplant (ITx).
26                                  Outcomes of intestinal transplants (ITx; n = 977) for pediatric pati
27 death (DBD) and on 46 patients on the active intestinal transplant list over 12 months from 14 April
28 d persistence of chimerism in a large animal intestinal transplant model.
29  registry graft survival data, the number of intestinal transplants necessary to demonstrate a no-mis
30                                Historically, intestinal transplant occurred primarily in the pediatri
31 e report of true operational tolerance in an intestinal transplant patient, we aim to demonstrate tha
32 s single center study reviews the records of intestinal transplant patients between 2004 and 2010.
33 wnregulated in the peripheral blood of three intestinal transplant patients during rejection.
34 n liver and kidney transplantation, and some intestinal transplant patients have been able to decreas
35                                A database of intestinal transplant patients was maintained with prosp
36                                We report two intestinal transplant patients who developed TMA while o
37 reports the management and complications for intestinal transplant patients with abdominal wall closu
38 od gene expression analysis was performed in intestinal transplant patients.
39 ons, would be a major advance in the care of intestinal transplant patients.
40 rs of graft rejection in peripheral blood of intestinal transplant patients.
41 minal allograft until the end of a prolonged intestinal transplant procedure would cause severe ische
42 ement strategies currently under evaluation, intestinal transplant procedures have the potential to b
43                              We evaluated an intestinal transplant recipient who required very large
44  jejunal and ileal tissue from one pediatric intestinal transplant recipient with severe gastroenteri
45                   A total of 168 consecutive intestinal transplant recipients (86 children and 82 adu
46     I-FABP was repetitively measured in nine intestinal transplant recipients and correlated with fin
47  blood spot (DBS) citrulline samples from 57 intestinal transplant recipients at or beyond 3 months p
48  months posttransplant among 445 consecutive intestinal transplant recipients at our institution sinc
49 st 60mo posttransplant among 445 consecutive intestinal transplant recipients at our institution sinc
50                    We reviewed results among intestinal transplant recipients before and after the in
51 ith biopsy is the standard method to monitor intestinal transplant recipients but it is invasive, cos
52 ndications of allograft rejection, pediatric intestinal transplant recipients do not have primary dis
53 examined: normal untreated controls, control intestinal transplant recipients kept in room air, and r
54                       A total of 22 isolated intestinal transplant recipients underwent graft enterec
55  and closure of the abdominal compartment in intestinal transplant recipients with complex abdominal
56 l alternative to assist graft enterectomy in intestinal transplant recipients without causing severe
57 gle center cohort of 245 consecutive primary intestinal transplant recipients, among which 93 receive
58 r, and management of PLP deficiency in adult intestinal transplant recipients.
59 onor colon should actively be considered for intestinal transplant recipients.
60 ions was maintained when evaluating only the intestinal transplant recipients.
61 LD, but its use has not yet been reported in intestinal transplant recipients.
62 ssociated with inferior graft outcomes among intestinal transplant recipients.
63                                          The Intestinal Transplant Registry (ITR) was created in 1985
64  Intestinal Failure and Transplantation, the Intestinal Transplant Registry, and the literature.
65                                              Intestinal transplant salvage was performed in four pati
66               Current outcomes indicate that intestinal transplants should be considered earlier in i
67 biliverdin would protect rat syngeneic small intestinal transplants (SITx) against damage and, if so,
68 5%, better in patients receiving an isolated intestinal transplant than a combined liver/bowel transp
69 ts 18 years or older (except those receiving intestinal transplants) transplanted between January 1,
70  13 months (range, 7-88), being assessed for intestinal transplant underwent simultaneous OGD and EUS
71                                              Intestinal transplants using cadaver donors have become
72                                              Intestinal transplants using living-related donors have
73                                              Intestinal transplant wait-list mortality is higher than
74  April 1998 to October 2004, 12 living donor intestinal transplants were performed in 11 patients (7
75                                   Thirty-one intestinal transplants were performed in 29 patients at
76                                  Sixty-seven intestinal transplants were performed in 65 patients fro
77      Children are the primary candidates for intestinal transplant with more than 70% requiring a com
78 the donor and recipient charts of all of our intestinal transplants with regard to the performance of
79 ved, leading to a reduction in the number of intestinal transplants worldwide from a peak of 270 per